Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.6, replacing the previous v3.6.5. The related topics section has been trimmed, removing items such as Lung cancer and MedlinePlus Genetics from the list.
    Difference
    0.2%
    Check dated 2026-09-02T19:38:42.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The study record now lists related topics and indexing terms (Lung cancer, related topics:, MedlinePlus Genetics). This enhances discoverability without altering core study details.
    Difference
    0.1%
    Check dated 2026-08-19T13:32:08.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.4 to v3.6.5, signaling a backend or UI update without changes to study details.
    Difference
    0.0%
    Check dated 2026-08-12T09:20:11.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page's related topics references were removed, reducing navigational links to external topic groups without altering the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-29T08:18:31.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.4 replacing the previous v3.6.3, indicating a minor update to the page template or rendering system.
    Difference
    0.0%
    Check dated 2026-07-22T00:14:08.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Adds links to Lung cancer and related topics, plus a MedlinePlus Genetics reference, providing background information and related resources for readers. The change does not modify the study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-07-07T14:47:20.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.